Erste Asset Management Gmb H Ptc Therapeutics, Inc. Transaction History

Erste Asset Management Gmb H

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 26, 2024	SELL	$22.41 - $41.99 $1.09 Million - $2.04 Million	-48,600 Closed	0 $0
Q3 2022 Nov 26, 2024	BUY	$41.85 - $53.85 $2.03 Million - $2.62 Million	48,600 New	48,600 $2.45 Billion
Q2 2022 Nov 26, 2024	BUY	$25.6 - $45.23 $1.24 Million - $2.2 Million	48,600 New	48,600 $1.96 Billion
Q1 2022 Nov 22, 2024	BUY	$33.33 - $44.6 $226,644 - $303,280	6,800 Added 16.27%	48,600 $1.81 Billion
Q4 2021 Nov 22, 2024	BUY	$35.36 - $41.86 $1.48 Million - $1.75 Million	41,800 New	41,800 $1.7 Billion
Q4 2020 Nov 22, 2024	SELL	$47.96 - $67.64 $767,360 - $1.08 Million	-16,000 Reduced 27.68%	41,800 $2.65 Billion
Q3 2020 Nov 22, 2024	BUY	$45.41 - $57.07 $2.62 Million - $3.3 Million	57,800 New	57,800 $2.73 Billion
Q2 2020 Nov 22, 2024	BUY	$42.56 - $54.98 $638,400 - $824,700	15,000 Added 35.05%	57,800 $2.93 Billion
Q1 2020 Nov 22, 2024	SELL	$32.37 - $59.36 $1.15 Million - $2.11 Million	-35,500 Reduced 45.34%	42,800 $1.82 Billion
Q4 2019 Nov 22, 2024	BUY	$32.22 - $50.07 $2.52 Million - $3.92 Million	78,300 New	78,300 $3.82 Billion
Q2 2019 Nov 22, 2024	BUY	$35.42 - $45.0 $2.77 Million - $3.52 Million	78,300 New	78,300 $3.38 Billion

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.